A pilot and feasibility study for a randomised controlled trial of 'Physio Direct' in primary health care
- Conditions
- Musculoskeletal conditions requiring physiotherapy in primary healthcareMusculoskeletal DiseasesUnspecified musculoskeletal conditions
- Registration Number
- ISRCTN14569653
- Lead Sponsor
- niversity of Bristol (UK)
- Brief Summary
o publication intended as of 09/11/2011
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 124
Adults consulting a General Practitioner (GP) in one of the general practices in the study and referred for musculoskeletal physiotherapy
1. Children (aged under 18 years)
2. Patients referred to physiotherapy by a hospital consultant
3. Patients requiring domiciliary physiotherapy (indicated by their GP)
4. Patients excluded by the referring GP or the senior physiotherapist, based on the referral form. This includes patients who appear unlikely to be able to complete a questionnaire in English. This is likely to include people with severe learning difficulties, dementia, or where the referral form indicated the patient would need an interpreter. Reasons for exclusion will be recorded
5. Patients excluded by a senior physiotherapist because their problem is too urgent to allow time for recruitment
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Designating primary and secondary outcomes is provisional since one aspect of this pilot study is to identify the best measures. Provisionally, the primary outcome is Measure Yourself Medical Outcome Profile (MYMOP2).
- Secondary Outcome Measures
Name Time Method <br> 1. Patient health status (using Short Form health survey [SF-36] and EuroQoL instrument [EQ-5D]).<br> 2. Patient perception of accessibility of care.<br> 3. Patient perception of improvement in symptoms.<br> 4. Patient satisfaction with care provided.<br> 5. Time lost from work due to the health problems for which physiotherapy is indicated.<br> 6. Patient preference for telephone or face-to-face assessment.<br> 7. Waiting times for treatment, based on service data.<br> 8. Did Not Attend (DNA) rates.<br>